High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Med...
- Autores
- Poirson, Juline; Suarez, Irina Paula; Straub, Marie Laure; Cousido Siah, Alexandra; Peixoto, Paul; Hervouet, Eric; Foster, Anne; Mitschler, Andre; Mukobo, Noella; Chebaro, Yassmine; Garcin, Dominique; Recberlik, Sevda; Gaiddon, Christian; Altschuh, Daniele; Nomine, Yves; Podjarny, Alberto Daniel; Trave, Gilles; Masson, Murielle
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Persistent infection with some mucosal a-genus human papillomaviruses (HPVs; the most prevalent one being HPV16) can induce cervical carcinoma, anogenital cancers, and a subset of head and neck squamous cell carcinoma (HNSCC). Cutaneous β-genus HPVs (such as HPV5 and HPV8) associate with skin lesions that can progress into squamous cell carcinoma with sun exposure in Epidermodysplasia verruciformis patients and immunosuppressed patients. Here, we analyzed mechanisms used by E6 proteins from the a- and β-genus to inhibit the interferon-b (IFNB1) response. HPV16 E6 mediates this effect by a strong direct interaction with interferon regulatory factor 3 (IRF3). The binding site of E6 was localized within a flexible linker between the DNAbinding domain and the IRF-activation domain of IRF3 containing an LxxLL motif. The crystallographic structure of the complex between HPV16 E6 and the LxxLL motif of IRF3 was solved and compared with the structure of HPV16 E6 interacting with the LxxLL motif of the ubiquitin ligase E6AP. In contrast, cutaneous HPV5 and HPV8 E6 proteins bind to the IRF3-binding domain (IBiD) of the CREβ-binding protein (CBP), a key transcriptional coactivator in IRF3-mediated IFN-b expression.
Fil: Poirson, Juline. Université de Strasbourg; Francia
Fil: Suarez, Irina Paula. Université de Strasbourg; Francia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario; Argentina
Fil: Straub, Marie Laure. Université de Strasbourg; Francia
Fil: Cousido Siah, Alexandra. Université de Strasbourg; Francia
Fil: Peixoto, Paul. Inserm; Francia
Fil: Hervouet, Eric. Inserm; Francia
Fil: Foster, Anne. Université de Strasbourg; Francia
Fil: Mitschler, Andre. Université de Strasbourg; Francia
Fil: Mukobo, Noella. Université de Strasbourg; Francia
Fil: Chebaro, Yassmine. Université de Strasbourg; Francia
Fil: Garcin, Dominique. Universite Ifm Geneve (ifm); Suiza
Fil: Recberlik, Sevda. Inserm; Francia
Fil: Gaiddon, Christian. Inserm; Francia
Fil: Altschuh, Daniele. Université de Strasbourg; Francia
Fil: Nomine, Yves. Université de Strasbourg; Francia
Fil: Podjarny, Alberto Daniel. Université de Strasbourg; Francia
Fil: Trave, Gilles. Université de Strasbourg; Francia
Fil: Masson, Murielle. Université de Strasbourg; Francia - Materia
-
HPV
INTERACTOMIC
INTERFERONS
IRF3
THREE-DIMENSIONAL STRUCTURE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/214484
Ver los metadatos del registro completo
id |
CONICETDig_f604ee3b3d9c07475ca0aa7bb58c43b1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/214484 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon ExpressionPoirson, JulineSuarez, Irina PaulaStraub, Marie LaureCousido Siah, AlexandraPeixoto, PaulHervouet, EricFoster, AnneMitschler, AndreMukobo, NoellaChebaro, YassmineGarcin, DominiqueRecberlik, SevdaGaiddon, ChristianAltschuh, DanieleNomine, YvesPodjarny, Alberto DanielTrave, GillesMasson, MurielleHPVINTERACTOMICINTERFERONSIRF3THREE-DIMENSIONAL STRUCTUREhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Persistent infection with some mucosal a-genus human papillomaviruses (HPVs; the most prevalent one being HPV16) can induce cervical carcinoma, anogenital cancers, and a subset of head and neck squamous cell carcinoma (HNSCC). Cutaneous β-genus HPVs (such as HPV5 and HPV8) associate with skin lesions that can progress into squamous cell carcinoma with sun exposure in Epidermodysplasia verruciformis patients and immunosuppressed patients. Here, we analyzed mechanisms used by E6 proteins from the a- and β-genus to inhibit the interferon-b (IFNB1) response. HPV16 E6 mediates this effect by a strong direct interaction with interferon regulatory factor 3 (IRF3). The binding site of E6 was localized within a flexible linker between the DNAbinding domain and the IRF-activation domain of IRF3 containing an LxxLL motif. The crystallographic structure of the complex between HPV16 E6 and the LxxLL motif of IRF3 was solved and compared with the structure of HPV16 E6 interacting with the LxxLL motif of the ubiquitin ligase E6AP. In contrast, cutaneous HPV5 and HPV8 E6 proteins bind to the IRF3-binding domain (IBiD) of the CREβ-binding protein (CBP), a key transcriptional coactivator in IRF3-mediated IFN-b expression.Fil: Poirson, Juline. Université de Strasbourg; FranciaFil: Suarez, Irina Paula. Université de Strasbourg; Francia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario; ArgentinaFil: Straub, Marie Laure. Université de Strasbourg; FranciaFil: Cousido Siah, Alexandra. Université de Strasbourg; FranciaFil: Peixoto, Paul. Inserm; FranciaFil: Hervouet, Eric. Inserm; FranciaFil: Foster, Anne. Université de Strasbourg; FranciaFil: Mitschler, Andre. Université de Strasbourg; FranciaFil: Mukobo, Noella. Université de Strasbourg; FranciaFil: Chebaro, Yassmine. Université de Strasbourg; FranciaFil: Garcin, Dominique. Universite Ifm Geneve (ifm); SuizaFil: Recberlik, Sevda. Inserm; FranciaFil: Gaiddon, Christian. Inserm; FranciaFil: Altschuh, Daniele. Université de Strasbourg; FranciaFil: Nomine, Yves. Université de Strasbourg; FranciaFil: Podjarny, Alberto Daniel. Université de Strasbourg; FranciaFil: Trave, Gilles. Université de Strasbourg; FranciaFil: Masson, Murielle. Université de Strasbourg; FranciaAmerican Society for Microbiology2022-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/214484Poirson, Juline; Suarez, Irina Paula; Straub, Marie Laure; Cousido Siah, Alexandra; Peixoto, Paul; et al.; High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression; American Society for Microbiology; Journal of Virology; 96; 10; 5-2022; 1-190022-538XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.01875-21info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:01:08Zoai:ri.conicet.gov.ar:11336/214484instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:01:09.177CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression |
title |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression |
spellingShingle |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression Poirson, Juline HPV INTERACTOMIC INTERFERONS IRF3 THREE-DIMENSIONAL STRUCTURE |
title_short |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression |
title_full |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression |
title_fullStr |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression |
title_full_unstemmed |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression |
title_sort |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression |
dc.creator.none.fl_str_mv |
Poirson, Juline Suarez, Irina Paula Straub, Marie Laure Cousido Siah, Alexandra Peixoto, Paul Hervouet, Eric Foster, Anne Mitschler, Andre Mukobo, Noella Chebaro, Yassmine Garcin, Dominique Recberlik, Sevda Gaiddon, Christian Altschuh, Daniele Nomine, Yves Podjarny, Alberto Daniel Trave, Gilles Masson, Murielle |
author |
Poirson, Juline |
author_facet |
Poirson, Juline Suarez, Irina Paula Straub, Marie Laure Cousido Siah, Alexandra Peixoto, Paul Hervouet, Eric Foster, Anne Mitschler, Andre Mukobo, Noella Chebaro, Yassmine Garcin, Dominique Recberlik, Sevda Gaiddon, Christian Altschuh, Daniele Nomine, Yves Podjarny, Alberto Daniel Trave, Gilles Masson, Murielle |
author_role |
author |
author2 |
Suarez, Irina Paula Straub, Marie Laure Cousido Siah, Alexandra Peixoto, Paul Hervouet, Eric Foster, Anne Mitschler, Andre Mukobo, Noella Chebaro, Yassmine Garcin, Dominique Recberlik, Sevda Gaiddon, Christian Altschuh, Daniele Nomine, Yves Podjarny, Alberto Daniel Trave, Gilles Masson, Murielle |
author2_role |
author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
HPV INTERACTOMIC INTERFERONS IRF3 THREE-DIMENSIONAL STRUCTURE |
topic |
HPV INTERACTOMIC INTERFERONS IRF3 THREE-DIMENSIONAL STRUCTURE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Persistent infection with some mucosal a-genus human papillomaviruses (HPVs; the most prevalent one being HPV16) can induce cervical carcinoma, anogenital cancers, and a subset of head and neck squamous cell carcinoma (HNSCC). Cutaneous β-genus HPVs (such as HPV5 and HPV8) associate with skin lesions that can progress into squamous cell carcinoma with sun exposure in Epidermodysplasia verruciformis patients and immunosuppressed patients. Here, we analyzed mechanisms used by E6 proteins from the a- and β-genus to inhibit the interferon-b (IFNB1) response. HPV16 E6 mediates this effect by a strong direct interaction with interferon regulatory factor 3 (IRF3). The binding site of E6 was localized within a flexible linker between the DNAbinding domain and the IRF-activation domain of IRF3 containing an LxxLL motif. The crystallographic structure of the complex between HPV16 E6 and the LxxLL motif of IRF3 was solved and compared with the structure of HPV16 E6 interacting with the LxxLL motif of the ubiquitin ligase E6AP. In contrast, cutaneous HPV5 and HPV8 E6 proteins bind to the IRF3-binding domain (IBiD) of the CREβ-binding protein (CBP), a key transcriptional coactivator in IRF3-mediated IFN-b expression. Fil: Poirson, Juline. Université de Strasbourg; Francia Fil: Suarez, Irina Paula. Université de Strasbourg; Francia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario; Argentina Fil: Straub, Marie Laure. Université de Strasbourg; Francia Fil: Cousido Siah, Alexandra. Université de Strasbourg; Francia Fil: Peixoto, Paul. Inserm; Francia Fil: Hervouet, Eric. Inserm; Francia Fil: Foster, Anne. Université de Strasbourg; Francia Fil: Mitschler, Andre. Université de Strasbourg; Francia Fil: Mukobo, Noella. Université de Strasbourg; Francia Fil: Chebaro, Yassmine. Université de Strasbourg; Francia Fil: Garcin, Dominique. Universite Ifm Geneve (ifm); Suiza Fil: Recberlik, Sevda. Inserm; Francia Fil: Gaiddon, Christian. Inserm; Francia Fil: Altschuh, Daniele. Université de Strasbourg; Francia Fil: Nomine, Yves. Université de Strasbourg; Francia Fil: Podjarny, Alberto Daniel. Université de Strasbourg; Francia Fil: Trave, Gilles. Université de Strasbourg; Francia Fil: Masson, Murielle. Université de Strasbourg; Francia |
description |
Persistent infection with some mucosal a-genus human papillomaviruses (HPVs; the most prevalent one being HPV16) can induce cervical carcinoma, anogenital cancers, and a subset of head and neck squamous cell carcinoma (HNSCC). Cutaneous β-genus HPVs (such as HPV5 and HPV8) associate with skin lesions that can progress into squamous cell carcinoma with sun exposure in Epidermodysplasia verruciformis patients and immunosuppressed patients. Here, we analyzed mechanisms used by E6 proteins from the a- and β-genus to inhibit the interferon-b (IFNB1) response. HPV16 E6 mediates this effect by a strong direct interaction with interferon regulatory factor 3 (IRF3). The binding site of E6 was localized within a flexible linker between the DNAbinding domain and the IRF-activation domain of IRF3 containing an LxxLL motif. The crystallographic structure of the complex between HPV16 E6 and the LxxLL motif of IRF3 was solved and compared with the structure of HPV16 E6 interacting with the LxxLL motif of the ubiquitin ligase E6AP. In contrast, cutaneous HPV5 and HPV8 E6 proteins bind to the IRF3-binding domain (IBiD) of the CREβ-binding protein (CBP), a key transcriptional coactivator in IRF3-mediated IFN-b expression. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/214484 Poirson, Juline; Suarez, Irina Paula; Straub, Marie Laure; Cousido Siah, Alexandra; Peixoto, Paul; et al.; High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression; American Society for Microbiology; Journal of Virology; 96; 10; 5-2022; 1-19 0022-538X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/214484 |
identifier_str_mv |
Poirson, Juline; Suarez, Irina Paula; Straub, Marie Laure; Cousido Siah, Alexandra; Peixoto, Paul; et al.; High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression; American Society for Microbiology; Journal of Virology; 96; 10; 5-2022; 1-19 0022-538X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1128/jvi.01875-21 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Society for Microbiology |
publisher.none.fl_str_mv |
American Society for Microbiology |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269678900084736 |
score |
13.13397 |